ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

13.70
-0.07
(-0.51%)
Closed July 30 4:00PM
13.5501
-0.1499
(-1.09%)
After Hours: 7:07PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
13.5501
Bid
-
Ask
-
Volume
6,187,734
13.62 Day's Range 13.875
0.00 52 Week Range 0.00
Market Cap
Previous Close
13.77
Open
13.86
Last Trade
4
@
13.7
Last Trade Time
Financial Volume
$ 85,001,991
VWAP
13.7372
Average Volume (3m)
-
Shares Outstanding
3,138,026,928
Dividend Yield
4.51%
PE Ratio
1.07
Earnings Per Share (EPS)
45.91
Revenue
4.28T
Net Profit
144.07B

About Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Headquarters
Chuo, Tokyo, Jpn
Founded
1984
Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TAK. The last closing price for Takeda Pharmaceutical was $13.77. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of $ 0.00 to $ 0.00.

Takeda Pharmaceutical currently has 3,138,026,928 shares outstanding. The market capitalization of Takeda Pharmaceutical is $43.21 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 1.07.

TAK Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AIUMeta Data Limited
$ 4.55
(87.24%)
12.66M
OISOil States International Inc
$ 5.39
(13.71%)
2.45M
AXRAMREP Corp
$ 25.72
(13.55%)
66.12k
PHGKoninklijke Philips NV
$ 29.15
(13.16%)
3.55M
WBXWallbox NV
$ 1.59
(11.97%)
641.59k
CTRICenturi Holdings Inc
$ 15.75
(-22.22%)
2.5M
TCSContainer Store Group Inc
$ 0.9625
(-19.79%)
3.99M
COURCoursera Inc
$ 9.355
(-12.73%)
8.88M
SMRNuScale Power Corporation
$ 9.49
(-12.53%)
16.22M
SBXC.USilverBox Corp III
$ 10.63
(-11.42%)
22.96k
FFord Motor Company
$ 11.015
(-1.56%)
91.8M
PFEPfizer Inc
$ 30.72
(-0.16%)
41.7M
BACBank of America Corporation
$ 41.09
(-1.39%)
37.13M
NIONIO Inc
$ 4.395
(-0.79%)
33.92M
DNAGinkgo Bioworks Holdings Inc
$ 0.366699
(-0.95%)
33.64M

TAK Discussion

View Posts
Monksdream Monksdream 4 months ago
TAK over $10
👍️0
Boing x 2 Boing x 2 1 year ago
Just saying,

https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

Other approved drug has serious side effects vs. ours.

300M cases a year from mosquito bites.

Boing X 2
👍️0
Phosphene Phosphene 4 years ago
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
👍️0
Phosphene Phosphene 4 years ago
Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
👍️0
Phosphene Phosphene 4 years ago
MIT-Takeda program launches

Research projects will harness the power of artificial intelligence to positively impact human health.

https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
👍️0
rising rising 6 years ago
Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

ADR is 3:1 - NICE!
60 percent upside
Added 36.83 US stock
Added 29.38 US cash


Not a bad deal!
👍️0
rising rising 6 years ago
So how does the Shire shareholder make out on this deal?

Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

Where is the 60percent premium to Close of March 27 2018 at shire 128.87
👍️0
trendmkr trendmkr 9 years ago
Takeda article: enGene Shines with a Host of Big Name Collaborations

http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
👍️0

Your Recent History

Delayed Upgrade Clock